NovoCure Ltd. (NVCR)
17.89
+1.06
(+6.30%)
USD |
NASDAQ |
May 08, 16:00
17.96
+0.07
(+0.39%)
After-Hours: 20:00
NovoCure Free Cash Flow : -48.07M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| LivaNova Plc | 161.04M |
| AtriCure, Inc. | 53.64M |
| LeMaitre Vascular, Inc. | 79.12M |
| Globus Medical, Inc. | 605.57M |
| Glaukos Corp. | -35.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.52M |
| Cash from Investing (Quarterly) | 7.747M |
| Cash from Financing (Quarterly) | -0.166M |
| Free Cash Flow Per Share (Quarterly) | -0.1635 |
| Free Cash Flow to Equity (Quarterly) | -5.256M |
| Free Cash Flow to Firm (Quarterly) | -16.78M |
| Free Cash Flow Yield | -2.39% |